BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $36,050,367 | +3.5% | 707,286 | +30.5% | 0.19% | -24.9% |
| Q2 2022 | $34,818,000 | -38.1% | 542,076 | -25.3% | 0.26% | -46.1% |
| Q1 2022 | $56,279,000 | +220.8% | 725,800 | +233.1% | 0.48% | +138.5% |
| Q2 2021 | $17,541,000 | +248.7% | 217,901 | +247.6% | 0.20% | +177.8% |
| Q4 2020 | $5,030,000 | -45.6% | 62,689 | -45.4% | 0.07% | -45.5% |
| Q3 2020 | $9,240,000 | +1310.7% | 114,901 | +1336.3% | 0.13% | -15.4% |
| Q2 2019 | $655,000 | -32.1% | 8,000 | -32.6% | 0.16% | +22.8% |
| Q1 2019 | $964,000 | +94.0% | 11,861 | +57.0% | 0.13% | -40.7% |
| Q4 2018 | $497,000 | -6.4% | 7,553 | +9.7% | 0.21% | +201.4% |
| Q3 2018 | $531,000 | +647.9% | 6,886 | +619.5% | 0.07% | +57.8% |
| Q2 2018 | $71,000 | -76.2% | 957 | -79.1% | 0.04% | -60.9% |
| Q1 2018 | $298,000 | – | 4,586 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
| Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
| Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
| TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
| GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
| Third Point | 4,000,000 | $344,400,000 | 4.72% |
| Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
| Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
| Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
| Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |